date,title,source
Oct-17-18,"Market Trends Toward New Normal in Halozyme Therapeutics, Fitbit, Iconix Brand Group, Leap Therapeutics, LightPath Technologies, and Capricor Therapeutics  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Oct-22-18,Capricor Therapeutics to Participate in Upcoming Conferences,GlobeNewswire
Nov-06-18,Capricor Therapeutics to Present Third Quarter Financial Results and Corporate Update on November 13,GlobeNewswire
Nov-07-18,Analysts Estimate Capricor Therapeutics (CAPR) to Report a Decline in Earnings: What to Look Out for,Zacks
Nov-08-18,Capricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International Conference,GlobeNewswire
Nov-12-18,Capricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical Trial,GlobeNewswire
Nov-13-18,"Capricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-13-18,Capricor: 3Q Earnings Snapshot,Associated Press
Nov-13-18,Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-28-18,"Research Report Identifies OraSure Technologies, Sierra Wireless, Seres Therapeutics, Lydall, ChromaDex, and Capricor Therapeutics with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Dec-04-18,Could The Capricor Therapeutics Inc (NASDAQ:CAPR) Ownership Structure Tell Us Something Useful?,Simply Wall St.
